Doseology Sciences Inc.

Doseology Sciences Inc. is a biotechnology-driven consumer products company focused on performance-driven innovation. The company engineers precision-formulated oral stimulants designed to optimize energy, focus, and cognitive performance. Its mission involves pioneering next-generation performance solutions through science-backed research and advanced delivery systems. The company's head office is located in Kelowna, British Columbia, Canada.

Doseology specializes in the rapidly emerging oral stimulant pouch category, developing a portfolio of science-backed, "better-for-you" stimulant pouches. These products include caffeine-based energy pouches and are designed as smoke-free, vapor-free alternatives to traditional stimulants. The company previously developed and sold functional mushroom products, including tinctures and powders, focused on mental health and wellness, under its own brand and through its subsidiary Dose Labs Inc.

Doseology Sciences Inc. has recently focused on expanding its presence in the oral stimulant pouch market. In March 2026, the company uplisted to the OTCQB Venture Market as DOSEF, aiming to expand U.S. investor access. They also launched "Feed That Brain" oral stimulant pouches in the U.S. through a direct-to-consumer pilot program in March 2026, following the acquisition of the "Feed That Brain" division in August 2025. The company secured $2 million in financing in March 2026 to accelerate the commercialization of its oral stimulant pouch platform. Chris Jackson serves as the CEO, and Larry Latowsky was appointed Executive Chairman of the Board of Directors in February 2026.